house · trading 2016-03-14 → 2026-03-31
*Purchases reported over roughly the last three years, weighted by the midpoint of each disclosed dollar band and marked to the latest close. Filings state a range, never a share count, so this tracks the stock rather than the position. It is not a dollar figure and it is not what this member made.
By recent-buy return, Harold Dallas Rogers ranks #38 of 118 lawmakers — better than 68% of Congress.
▮ buys · ▮ sells
| Date | Ticker | Type | Amount | Est. price | Latest close | Return |
|---|---|---|---|---|---|---|
| 2026-03-31 | SPY | BUY | $1K–$15K | $650.34 | $765.37 2026-10-26 | +17.7% |
| 2025-11-24 | T | SELL | $1K–$15K | $25.62 | $25.68 2026-09-04 | -0.2% exit |
| 2024-05-09 | VWO | SELL | $1K–$15K | $43.37 | $56.50 2026-10-26 | -30.3% exit |
| 2024-05-09 | IVV | SELL | $1K–$15K | $522.66 | $768.69 2026-10-26 | -47.1% exit |
| 2024-05-09 | IJS | SELL | $1K–$15K | $100.98 | $131.83 2026-10-26 | -30.6% exit |
| 2024-05-09 | BBL | SELL | $1K–$15K | — | — | — exit |
| 2024-04-16 | VWO | BUY | $1K–$15K | $40.83 | $56.50 2026-10-26 | +38.4% |
| 2024-04-16 | IVV | BUY | $1K–$15K | $505.98 | $768.69 2026-10-26 | +51.9% |
| 2024-04-16 | IJS | BUY | $1K–$15K | $94.66 | $131.83 2026-10-26 | +39.3% |
| 2024-04-16 | IEMG | BUY | $1K–$15K | $50.04 | $75.26 2026-10-26 | +50.4% |
| 2024-04-16 | BGL | BUY | $1K–$15K | — | — | — |
| 2024-04-16 | BGB | BUY | $1K–$15K | $11.67 | $10.94 2026-10-26 | -6.3% |
| 2024-04-16 | BBL | BUY | $1K–$15K | — | — | — |
| 2024-03-31 | SPY | BUY | $1K–$15K | $523.07 | $765.37 2026-10-26 | +46.3% |
| 2021-03-25 | GSK | BUY | $1K–$15K | $36.07 | $51.10 2026-10-26 | +41.7% |
| 2021-03-16 | VWO | BUY | $1K–$15K | $53.07 | $56.50 2026-10-26 | +6.5% |
| 2021-03-16 | HYT | BUY | $1K–$15K | $11.45 | $8.23 2026-08-21 | -28.1% |
| 2021-03-16 | GSK | BUY | $1K–$15K | $36.35 | $51.10 2026-10-26 | +40.6% |
| 2021-03-16 | BND | BUY | $1K–$15K | $84.74 | $71.27 2026-10-26 | -15.9% |
| 2017-09-11 | HCA | BUY | $1K–$15K | $78.35 | $465.26 2026-10-26 | +493.8% |
| 2017-09-07 | ZTS | BUY | $1K–$15K | $64.85 | $77.73 2026-08-21 | +19.9% |
| 2017-09-07 | O | BUY | $1K–$15K | $56.89 | $57.16 2026-10-26 | +0.5% |
| 2016-03-24 | QCOM | BUY | $1K–$15K | $50.86 | $168.74 2026-09-04 | +231.8% |
| 2016-03-24 | PYPL | BUY | $1K–$15K | $38.92 | $54.96 2026-09-04 | +41.2% |
| 2016-03-15 | ROK | BUY | $1K–$15K | $107.18 | $433.81 2026-09-04 | +304.8% |
| 2016-03-15 | BFB | BUY | $1K–$15K | $95.77 | — | — |
| 2016-03-14 | MRK | BUY | $1K–$15K | $53.08 | $150.33 2026-09-04 | +183.2% |
Buys are marked to the latest close and treated as still open. A sell tagged rt closes an earlier disclosed buy in the same name. exit reads from the seller's side: how the stock moved after they were out.
| Member | Shared tickers |
|---|---|
| Rohit Khanna | 11 · GSK, T, BFB, MRK, PYPL, QCOM |
| Michael T. McCaul | 8 · IVV, T, MRK, PYPL, QCOM, ROK |
| James B. Renacci | 8 · GSK, IVV, T, MRK, PYPL, QCOM |
| Thomas R Carper | 8 · GSK, IEMG, IJS, IVV, PYPL, QCOM |
| John Boozman | 8 · BND, GSK, VWO, IVV, PYPL, QCOM |
| Kurt Schrader | 8 · GSK, VWO, IJS, T, PYPL, QCOM |
| David A Perdue , Jr | 7 · T, MRK, PYPL, QCOM, HCA, ZTS |
| Alan S. Lowenthal | 7 · IEMG, T, MRK, PYPL, HCA, ZTS |
| Thomas H Tuberville | 7 · GSK, IVV, MRK, PYPL, QCOM, ROK |
| Charles J. "Chuck" Fleischmann | 7 · BND, GSK, IEMG, IJS, PYPL, ZTS |
| Josh Gottheimer | 6 · T, MRK, PYPL, ROK, HCA, SPY |
| Alan Armstrong | 6 · T, MRK, PYPL, QCOM, HCA, O |